Non-Hodgkin’s lymphoma affecting the testis: Is it curable with doxorubicin-based therapy?

Clinical Lymphoma

Volumn 2, Issue 1, 2001, Pages 40-46

  Visco, Carlo ^a   Medeiros, L Jeffrey ^a   Mesina, Ofelia M ^a   Rodriguez, Maria A ^a   Hagemeister, Frederick B ^a   McLaughlin, Peter ^a   Romaguera, Jorge E ^a   Cabanillas, Fernando ^a   Sarris, Andreas H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Burkitt's lymphoma; Central nervous system; Diffuse large cell lymphoma; Gonads; Prophylactic scrotal radiation

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; PROGNOSIS; SCORING SYSTEM; TESTIS CANCER; TREATMENT FAILURE;

EID: 0034919721     PISSN: 15269655     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2001.n.010     Document Type: Article

References (46)

1. Malignant lymphoma of the testis
2. Testicular lymphoma: A population-based study of incidence, clinicopathological correlations and prognosis
3. Lymphomas of the testis - Results of treatment 1960-77
4. Malignant lymphoma with primary manifestation in the gonad: A clinicopathologic study of 38 patients
5. Non-Hodgkin's lymphoma of the testis
6. Testicular lymphoma
7. Primary testicular non-Hodgkin's lymphoma: A clinical study and review of the literature
8. Testicular lymphoma: Late relapses and poor outcome despite doxorubicin-based therapy
9. Aggressive T/natural killer cell lymphoma presenting as testicular tumor
10. Lymphomas with testicular localisation show a consistent BCL-2 expression without a translocation (14;18): A molecular and immunohistochemical study
11. Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis
12. Solitary testicular plasmacytoma
13. Extranodal non-Hodgkin's lymphoma presenting in the testicle: A clinical and pathologic study of 24 cases
14. Malignant lymphoma of the testis: A clinicopathologic study of 37 cases
15. Metastatic tumours in the testis
16. The extranodal lymphomas
17. Stage IE nonHodgkin's lymphoma of the testis: A need for a brief aggressive chemotherapy
18. The management and outcome of stage IAE nonHodgkin's lymphoma of the testis
19. Patterns of failure in primary testicular non-Hodgkin's lymphoma
20. Testicular lymphoma: Improved outcome with early brief chemotherapy
21. Non-Hodgkin lymphoma of the testis
22. Testicular lymphoma is associated with a high incidence of extranodal recurrence
23. Diffuse large-cell lymphoma of the testis
24. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage
25. A predictive model for aggressive non-Hodgkin's lymphoma
26. A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'
27. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma
28. A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma
29. Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma
30. Successful outcome of patients with good risk large cell lymphoma (LCL) with a shortened schedule of treatment (RX)
31. Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma
32. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin-vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis
33. Randomized study of idarubicin (IDA) vs adriamycin (Adria)-based combination chemotherapy for aggressive poor prognosis (tumor score >=3) non-Hodgkin's lymphomas
34. Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in advanced non-Hodgkin's lymphomas
35. Nonparametric estimation from incomplete observations
36. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples
37. Lack of adhesion molecules in testicular diffuse centroblastic and immunoblastic B cell lymphomas as a contributory factor in malignant behaviour
38. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites
39. Molecular pathological analysis of testicular diffuse large cell lymphomas
40. Recent advances in the molecular pathogenesis of lymphomas
41. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma
42. Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity
43. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection
44. Molecular analysis of human immunoglobulin heavy chain variable genes (IgVH) in normal and malignant B cells